Core Services
JACDA, LLC provides Clinical & Translational Research Solutions that help healthcare, biotechnology, diagnostic, and research organizations move environmental-exposure and pulmonary/respiratory disease-risk science from complex data into clinically relevant strategies — the same disciplines below, applied to one focused niche.A. Clinical Research Strategy – Design smarter clinical and translational studies.
B. Diagnostic Development Support – Advance diagnostics from idea to validated solution.
C. Translational Research – Bridge preclinical insights to clinical impact.
D. Scientific Grant Development – Strengthen grant strategy, proposals, and scientific storytelling to win funding.
E. Scientific Training – Build skills in research methods, diagnostics, and scientific communication.
A. Clinical Research Strategy
JACDA supports clinical and translational research from concept through execution with strategic guidance across study design, endpoints, and evidence generation, with particular depth in pulmonary, respiratory, and environmental-exposure study design.
- • Study Design
• Translational Research Planning
• Biomarker Strategy
• Clinical Endpoint Development
• Research Protocol Development
• Literature / Scientific Evidence Assessments
B. Diagnostic Development Support
JACDA provides end-to-end support for diagnostic development, from early concept evaluation through validation and regulatory planning, with a focus on pulmonary and respiratory disease-risk diagnostics.
- • Diagnostic Concept Evaluation
• Biomarker Assessment
• Assay Development Strategy
• Analytical Validation Planning
• Clinical Validation Strategy
• Regulatory Pathway Assessment
C. Translational Research
JACDA bridges preclinical and clinical work using advanced translational and nanotechnology approaches to accelerate diagnostic impact for pulmonary, respiratory, and environmental-exposure applications.
- • Preclinical-to-clinical translation
• Experimental design
• Nanotechnology research strategy
• Drug-delivery research
• Tumor microenvironment research
• Pharmacology/toxicology interpretation
D. Scientific Grant Development
JACDA supports investigators and organizations in securing competitive funding through strategic grant planning and scientific storytelling, frequently for pulmonary, respiratory, and environmental-health research programs.
- • NIH SBIR/STTR Strategy
• Research Proposal Development
• Specific Aims Development
• Research Strategy Development
• Commercialization Strategy
• Scientific Editing
E. Scientific Training
JACDA offers targeted scientific training to strengthen skills across research methods, pharmacology, translational and clinical research, diagnostics, and scientific communication, with case examples drawn from pulmonary and environmental-exposure research.
- • Research Methodology Workshops
• Pharmacology
• Translational Research
• Clinical Research
• Diagnostic Development
• Scientific Writing
Four ways to work with JACDA, scoped and priced against current market rates for comparable PhD-level biomedical consulting.
Packages & Investment
Discovery & Diagnostic Strategy Consultation — $2,500–$4,500 flat fee
For startups, tech-transfer offices, and CROs weighing a pulmonary/respiratory or environmental-exposure angle. A focused 2–3 week engagement — review of existing data or protocols, and a written strategic assessment.
Grant & Scientific Program Development — $5,000–$8,000 per proposal
For academic PIs and small biotechs pursuing NIH, NSF, or SBIR/STTR funding in pulmonary, respiratory, or environmental-exposure research. Full proposal development, submission support, and one resubmission review round.
Contract Research & Data Analytics Engagement — $15,000–$40,000 per project
For biotech, pharma, and academic partners needing biomarker analysis or translational research support. A defined-scope project — research design, analysis, and a final report, typically 2–4 months.
Strategic Advisory Retainer — $3,000–$6,000/month
For companies wanting ongoing, embedded scientific expertise without hiring a full-time Chief Scientific Officer. 15–25 advisory hours per month — review of protocols, data, and grant drafts, plus participation in key strategic or scientific meetings, 3-month minimum.
FAQ: Working With JACDA
What Clinical & Translational Research Solutions does JACDA provide?
We specialize in Clinical & Translational Research Solutions across clinical research strategy, diagnostic development support, translational research, scientific grant development, and scientific training, with particular focus on pulmonary, respiratory, and environmental-exposure disease risk.
How do you support early-stage diagnostic innovation?
JACDA helps teams move from concept to clinically relevant strategies by supporting study design, biomarker and assay strategy, validation planning, and translational pathways for diagnostics.
Can you assist with scientific grant development and training?
Yes. We support scientific grant development through proposal strategy, Specific Aims and Research Strategy development, and scientific editing, and we offer training in research methods, diagnostics, and scientific communication.